{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:07:55Z","timestamp":1767211675056,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bmc.2023.117290","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T17:00:52Z","timestamp":1682010052000},"page":"117290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of acyl sulfonamide derivatives with spiro cycles as NaV1.7 inhibitors for antinociception"],"prefix":"10.1016","volume":"86","author":[{"given":"Xiangshuo","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengqi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heling","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-3839","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KeWei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117290_b0005","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The Revised International Association for The Study of Pain Definition of Pain","volume":"161","author":"Sn","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.bmc.2023.117290_b0010","unstructured":"Pain Market to 2027. Available from: https:\/\/www.alliedmarketresearch.com\/pain-management-therapeutics-market."},{"key":"10.1016\/j.bmc.2023.117290_b0015","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid Complications and Side Effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.bmc.2023.117290_b0020","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid Pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.bmc.2023.117290_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-Steroidal Anti-Inflammatory Drugs (Nsaids) and Organ Damage: A Current Perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2023.117290_b0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/d41573-019-00065-0","article-title":"Nav1.7 Withholds Its Pain Potential","volume":"18","author":"Kingwell","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2023.117290_b0035","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1111\/bph.15327","article-title":"Fifteen Years of Na(V) 1.7 Channels as an Analgesic Target: Why Has Excellent In Vitro Pharmacology Not Translated Into In Vivo Analgesic Efficacy?","volume":"179","author":"Eagles","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117290_b0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature09975","article-title":"Loss-of-function Mutations in Sodium Channel Nav1.7 Cause Anosmia","volume":"472","author":"Weiss","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117290_b0045","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/brain\/aws225","article-title":"Neurological Perspectives on Voltage-Gated Sodium Channels","volume":"135","author":"Eijkelkamp","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bmc.2023.117290_b0050","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/acs.jmedchem.1c00028","article-title":"Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery","volume":"64","author":"Obeng","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117290_b0055","doi-asserted-by":"crossref","first-page":"p. aac5464","DOI":"10.1126\/science.aac5464","article-title":"Structural Basis of Nav1.7 Inhibition by an Isoform-Selective Small-Molecule Antagonist","volume":"350","author":"Ahuja","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117290_b0060","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/acs.jmedchem.8b01621","article-title":"Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na(V)) 1.7 with Potent Analgesic Activity","volume":"62","author":"Sun","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117290_b0065","unstructured":"Guan DL et al. N-(Substituted Sulfonyl)Benzamide Derivative, Preparation Method Therefor, and Pharmaceutical Use Thereof 2019:WO2019062848A1."},{"key":"10.1016\/j.bmc.2023.117290_b0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.jmedchem.0c01473","article-title":"Spirocyclic Scaffolds in Medicinal Chemistry","volume":"64","author":"Hiesinger","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117290_b0075","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: Expanding the Scope of the Protein-Ligand Interaction Profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117290_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00540-017-2427-y","article-title":"Central Noradrenergic Activity Affects Analgesic Effect of Neuropeptide S","volume":"32","author":"Jinushi","year":"2018","journal-title":"J Anesth"},{"key":"10.1016\/j.bmc.2023.117290_b0085","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1021\/acs.jmedchem.2c00014","article-title":"SLL-627 Is a Highly Selective and Potent kappa Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor Activity","volume":"65","author":"Kong","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117290_b0090","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cclet.2021.08.026","article-title":"Design and Synthesis of Novel \u03b1-aminoamides Derivatives as Nav1.7 Inhibitors for Antinociception","volume":"33","author":"Xue","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmc.2023.117290_b0095","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41401-021-00682-9","article-title":"Inhibition of Nav1.7 Channel by a Novel Blocker QLS-81 for Alleviation of Neuropathic Pain","volume":"42","author":"Niu","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmc.2023.117290_b0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.108.142802","volume":"329","author":"Wang","year":"2009","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:21:53Z","timestamp":1760836913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":20,"alternative-id":["S0968089623001384"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117290","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of acyl sulfonamide derivatives with spiro cycles as NaV1.7 inhibitors for antinociception","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117290"}}